{"id":24377,"date":"2025-04-13T17:41:36","date_gmt":"2025-04-13T17:41:36","guid":{"rendered":"https:\/\/researchchemworld.com\/?post_type=product&#038;p=24377"},"modified":"2026-02-25T16:23:00","modified_gmt":"2026-02-25T16:23:00","slug":"maxtc-5-mapb-4-fma-5-meo-mipt","status":"publish","type":"product","link":"https:\/\/researchchemworld.com\/nb\/butikk\/kjop-4fma\/maxtc-5-mapb-4-fma-5-meo-mipt\/","title":{"rendered":"MaXTC 5-MAPB\/4-FMA\/5-MeO-MiPT"},"content":{"rendered":"<h1><strong>Produktdefinisjon: MaXTC 5-MAPB \/ 4-FMA \/ 5-MeO-MiPT-pellets<\/strong><\/h1>\n<p class=\"ds-markdown-paragraph\"><strong>Sammensetning per pellet (mikroinnkapslet):<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MAPB (5-metoksy-3,4-metylendioksyamfetamin):<\/strong>\u00a060 mg<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>4-FMA (4-fluormetamfetamin):<\/strong>\u00a040 mg<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MeO-MiPT (5-metoksy-N-metyl-N-isopropyltryptamin):<\/strong>\u00a05 mg<br \/>\n<strong>Skjema:<\/strong>\u00a0Ensartede pellets med langsom frigj\u00f8ring<br \/>\n<strong>Utseende:<\/strong>\u00a0Lysfargede, runde tabletter (\u00b1 220 mg hver)<br \/>\n<strong>CAS-numre:<\/strong><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MAPB: 1354631-79-7<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">4-FMA: 351-03-1<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MeO-MiPT: 96096-55-8<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Beskrivelse og virkningsmekanisme<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong>MaXTC<\/strong>\u00a0er en\u00a0<strong>Kraftig, balansert entaktogen og stimulerende blanding<\/strong>, designet for en\u00a0<strong>en kombinasjon av empati, energi og milde psykedeliske effekter<\/strong>.<\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MAPB<\/strong>\u00a0\u279c Prim\u00e6r\u00a0<strong>serotonergisk empatogen effekt<\/strong>\u00a0(ligner p\u00e5 MDMA, men mykere)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>4-FMA<\/strong>\u00a0\u279c\u00a0<strong>Dopaminerg\/noradrenerg stimulant<\/strong>\u00a0for energi og fokus<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MeO-MiPT<\/strong>\u00a0\u279c\u00a0<strong>Lett psykedelisk fargetone<\/strong>\u00a0(sensorisk forsterkning, emosjonell dybde)<\/p>\n<\/li>\n<\/ul>\n<h3><strong>Prim\u00e6re effekter:<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2714 Sterk\u00a0<strong>emosjonell tilknytning<\/strong>\u00a0(MDMA-lignende)<br \/>\n\u2714 Langvarig\u00a0<strong>fysisk energi<\/strong>\u00a0uten et kraftig brak<br \/>\n\u2714 Subtil\u00a0<strong>visuell og taktil forsterkning<\/strong><br \/>\n\u2714\u00a0<strong>Mindre kjevebiting<\/strong>\u00a0enn med rene sentralstimulerende midler<\/p>\n<hr \/>\n<h2><strong>Brukstilfeller og applikasjoner<\/strong><\/h2>\n<h3><strong>1. Sosial og festlig bruk<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Festivaler, klubber og fester<\/strong>\u00a0\u2013 Langvarig energi + empati.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Dype samtaler og kontakt<\/strong>\u00a0\u2013 Mindre kraftig enn ren MDMA.<\/p>\n<\/li>\n<\/ul>\n<h3><strong>2. Terapeutiske muligheter (eksperimentelle)<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Muligens nyttig for\u00a0<strong>emosjonell bearbeiding<\/strong>\u00a0(ikke klinisk unders\u00f8kt).<\/p>\n<\/li>\n<\/ul>\n<h3><strong>3. Forskningsform\u00e5l<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Studer p\u00e5\u00a0<strong>kombinasjonseffekter av entaktogener, stimulanter og tryptaminer<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Fordeler med MaXTC-pellets<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Balansert \u00abTrifecta\u00bb-action<\/strong><br \/>\n\u2192 Empati (5-MAPB) + Energi (4-FMA) + Sensorisk dybde (5-MeO-MiPT)<\/p>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Lengre virkningstid (~6\u20138 timer)<\/strong><br \/>\n\u2192 F\u00e6rre gjentatte doser n\u00f8dvendig.<\/p>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Mindre \u00abnedtur\u00bb enn MDMA<\/strong><br \/>\n\u2192 Takket v\u00e6re gradvis frigj\u00f8ring.<\/p>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>N\u00f8yaktig dosert<\/strong><br \/>\n\u2192 Reduserer risikoen for overdosering.<\/p>\n<hr \/>\n<h2><strong>Ulemper og risikoer<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u274c\u00a0<strong>Ingen kliniske data<\/strong>\u00a0\u2192 Ukjente langsiktige risikoer.<br \/>\n\u274c\u00a0<strong>Mulige bivirkninger:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Hjertebank<\/strong>\u00a0(av 4-FMA)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Mild angst<\/strong>\u00a0(5-MeO-MiPT i h\u00f8yere doser)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Dehydrering<\/strong>\u00a0(p\u00e5 grunn av stimulerende effekt)<br \/>\n\u274c\u00a0<strong>Potensielt vanedannende<\/strong>\u00a0\u2192 Dopamineffekten av 4-FMA kan for\u00e5rsake sug.<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Anbefalt dosering og bruk<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u26a0\u00a0<strong>Advarsel:<\/strong>\u00a0Kun for forskningsform\u00e5l.\u00a0<strong>Ikke til menneskelig konsum.<\/strong><\/p>\n<div class=\"markdown-table-wrapper\">\n<table>\n<thead>\n<tr>\n<th>M\u00e5l<\/th>\n<th>Dosering<\/th>\n<th>Effektens varighet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Milde effekter<\/strong><\/td>\n<td>\u00bd pellet (~30mg 5-MAPB \/ 20mg 4-FMA \/ 2,5mg 5-MeO-MiPT)<\/td>\n<td>5\u20136 timer<\/td>\n<\/tr>\n<tr>\n<td><strong>Standard dosering<\/strong><\/td>\n<td><strong>1 pellet (60\/40\/5 mg)<\/strong><\/td>\n<td>6\u20138 timer<\/td>\n<\/tr>\n<tr>\n<td><strong>Erfarne brukere<\/strong><\/td>\n<td>Maks.\u00a0<strong>1,5 pellets (90\/60\/7,5 mg)<\/strong><\/td>\n<td>8+ timer (anbefales ikke for nybegynnere)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><strong>Administrasjon:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Kun muntlig<\/strong>\u00a0(ikke sniff\/injiser).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Operasjonen starter etter\u00a0<strong>~45\u201360 minutter<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><strong>Tips for sikker bruk:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Hydrer<\/strong>\u00a0(men ikke overdrevet).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Ta pauser<\/strong>\u00a0(min. 4\u20136 uker mellom hver bruk).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Bruk i trygge omgivelser<\/strong>\u00a0(helst med reisepasser).<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Ofte stilte sp\u00f8rsm\u00e5l (FAQ)<\/strong><\/h2>\n<h3><strong>1. Er MaXTC lovlig i Nederland?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Sannsynligvis ulovlig<\/strong>\u00a0under opiumsloven (alle komponenter er regulert eller gr\u00e5sone).<\/p>\n<h3><strong>2. Hvordan er dette forskjellig fra vanlig ecstasy\/MDMA?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Mindre euforisk, men mer balansert<\/strong>\u00a0(mindre \u00abrulling\u00bb, mer kontrollert energi).<\/p>\n<h3><strong>3. Kan jeg kombinere dette med alkohol eller andre rusmidler?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Absolutt ikke anbefalt!<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Alkohol<\/strong>\u00a0\u2192 \u00d8kt dehydrering\/toksisitet.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Psykoaktive stoffer<\/strong>\u00a0\u2192 Uforutsigbare interaksjoner.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>MAO-hemmere<\/strong>\u00a0\u2192\u00a0<strong>Ekstremt farlig!<\/strong><\/p>\n<\/li>\n<\/ul>\n<h3><strong>4. Er det risiko for serotonergt syndrom?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Teoretisk mulig<\/strong>\u00a0ved kombinasjonen 5-MAPB + 5-MeO-MiPT \u2192\u00a0<strong>Ikke kombiner med SSRI\/MAO-hemmere!<\/strong><\/p>\n<h3><strong>5. Hvordan f\u00f8les det \u00e5 komme seg tilbake?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Mildere enn MDMA<\/strong>\u00a0(mindre emosjonell nedgang), men litt erfaring\u00a0<strong>mild tretthet\/s\u00f8vnvansker<\/strong>.<\/p>\n<hr \/>\n<h2><strong>Labrapport og kvalitetskontroll<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong>Analyse av en standardbatch:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Renhet:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MAPB: \u226597%<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">4-FMA: \u226595%<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MeO-MiPT: \u226598%<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Resterende l\u00f8semidler:<\/strong>\u00a0&lt;1%<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Doseringskonsistens:<\/strong>\u00a0\u00b13% variasjon per pellet<\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><strong>Stabilitet:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Holdbarhet:<\/strong>\u00a0<strong>18\u201324 m\u00e5neder<\/strong>\u00a0(oppbevares kj\u00f8lig, m\u00f8rkt og t\u00f8rt).<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Konklusjon og sikkerhetsr\u00e5d<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong>MaXTC<\/strong>\u00a0er en\u00a0<strong>kraftig, allsidig blanding<\/strong>\u00a0for de som leter etter en\u00a0<strong>alternativ til tradisjonelle empatogener<\/strong>, men p\u00e5 grunn av\u00a0<strong>ukjente risikoer<\/strong>\u00a0er\u00a0<strong>ekstrem forsiktighet<\/strong>\u00a0tilbudt.<\/p>\n<p class=\"ds-markdown-paragraph\">\u26a0\u00a0<strong>ANSVARSFRASKRIVELSE:<\/strong>\u00a0Dette produktet er\u00a0<strong>kun for forskningsform\u00e5l<\/strong>\u00a0og\u00a0<strong>ikke beregnet for konsum<\/strong>.<a href=\"https:\/\/researchchemworld.com\/nb\/butikk\/iboga-ibogain\/kjop-ibogaine-hcl-pa-nett\/\">kj\u00f8p ibogaine hcl p\u00e5 nett<\/a><a href=\"https:\/\/researchchemworld.com\/nb\/butikk\/iboga-ibogain\/iboga-rotbark\/\">iboga rotbark<\/a><a href=\"https:\/\/researchchemworld.com\/nb\/butikk\/lysergamider\/1cp-lsd\/\">1cp lsd<\/a><a href=\"https:\/\/researchchemworld.com\/nb\/butikk\/pellets-for-pellets\/o-dsmt-50-mg-pellets\/\">o-dsmt<\/a><a href=\"https:\/\/researchchemworld.com\/nb\/butikk\/lysergamider\/1vlsd\/\">1vlsd<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Produktdefinisjon: MaXTC 5-MAPB \/ 4-FMA \/ 5-MeO-MiPT-pellets Sammensetning per pellet (mikroinnkapslet): 5-MAPB (5-metoksy-3,4-metylendioksyamfetamin): 60 mg 4-FMA (4-fluormetamfetamin): 40 mg 5-MeO-MiPT (5-metoksy-N-metyl-N-isopropyltryptamin): 5<\/p>","protected":false},"featured_media":29381,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[459,460,383,433,436,434,339,322,333,467,468,324,381],"product_tag":[664,326],"class_list":{"0":"post-24377","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-4fma-kopen","7":"product_cat-4-fma-pellets","8":"product_cat-5-mapb","9":"product_cat-5-mapb-pellets","10":"product_cat-5-meo-mipt","11":"product_cat-5-meo-mipt-pellets","12":"product_cat-benzofuran","13":"product_cat-bijna-verboden","14":"product_cat-gefluoreerden","15":"product_cat-maxtc","16":"product_cat-maxtc-pellets","17":"product_cat-pellets-for-pellet","18":"product_cat-tryptamines","19":"product_tag-maxtc","20":"product_tag-nl","22":"first","23":"instock","24":"taxable","25":"shipping-taxable","26":"purchasable","27":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product\/24377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/comments?post=24377"}],"version-history":[{"count":4,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product\/24377\/revisions"}],"predecessor-version":[{"id":26501,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product\/24377\/revisions\/26501"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/media\/29381"}],"wp:attachment":[{"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/media?parent=24377"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product_brand?post=24377"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product_cat?post=24377"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemworld.com\/nb\/wp-json\/wp\/v2\/product_tag?post=24377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}